⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mycophenolate mofetil

Every month we try and update this database with for mycophenolate mofetil cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesNCT01175785
Accelerated Pha...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Chron...
Childhood Myelo...
Chronic Phase C...
de Novo Myelody...
Previously Trea...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Relapsing Chron...
Secondary Myelo...
umbilical cord ...
fludarabine pho...
cyclophosphamid...
ex vivo-expande...
total-body irra...
cyclosporine
mycophenolate m...
laboratory biom...
6 Months - 45 YearsNohla Therapeutics, Inc.
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaNCT00453388
Acute Myeloid L...
de Novo Myelody...
Fanconi Anemia
Previously Trea...
Allogeneic Bone...
Cyclophosphamid...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Nonmyeloablativ...
Total-Body Irra...
- Fred Hutchinson Cancer Center
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantNCT02333162
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Hemat...
Fludarabine Pho...
Melphalan
Intensity-Modul...
Total Marrow Ir...
Allogeneic Hema...
Peripheral Bloo...
Allogeneic Bone...
Tacrolimus
Mycophenolate M...
Laboratory Biom...
18 Years - 75 YearsUniversity of Chicago
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesNCT00795132
Acute Leukaemia
Chronic Disease
Leukemia
Myelodysplasia
Lymphoma
Busulfan
Anti-Thymocyte ...
Fludarabine
Cyclosporine
Mycophenolate m...
- 21 YearsUniversity of Utah
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerNCT00723099
Acute Lymphobla...
Acute Myeloid L...
Aggressive Non-...
Chronic Myeloge...
Chronic Phase C...
Indolent Non-Ho...
Lymphoma
Mixed Phenotype...
Myelodysplastic...
Myeloproliferat...
Recurrent Chron...
Recurrent Folli...
Recurrent Lymph...
Recurrent Mantl...
Recurrent Margi...
Recurrent Plasm...
Recurrent Small...
Recurrent T-Cel...
Refractory Chro...
Refractory Chro...
Refractory Foll...
Refractory Hodg...
Refractory Lymp...
Refractory Mant...
Refractory Smal...
T-Cell Non-Hodg...
Allogeneic Hema...
Cyclophosphamid...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Total-Body Irra...
Umbilical Cord ...
- 69 YearsFred Hutchinson Cancer Center
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSNCT01300572
Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center
Optimizing PTCy Dose and TimingNCT03983850
Graft Versus Ho...
Hematologic Neo...
Busulfan
Fludarabine
Cyclophosphamid...
Mycophenolate M...
Sirolimus
12 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic MalignanciesNCT01203722
Hematologic Mal...
Fludarabine
Cytoxan
Total Body Irra...
Allogeneic Bloo...
Peripheral Bloo...
Mycophenolate M...
Sirolimus
Tacrolimus
6 Months - 75 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationNCT01810588
Hematologic Mal...
CliniMACS® CD34...
Fludarabine
Melphalan
anti-thymocyte ...
Rituximab
Total Body Irra...
Mycophenolate M...
Tacrolimus
18 Years - Weill Medical College of Cornell University
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary MyelofibrosisNCT03118492
Secondary Myelo...
Allogeneic Hema...
Cyclophosphamid...
Fludarabine
Glycosylated Re...
Laboratory Biom...
Melphalan
Mycophenolate M...
Tacrolimus
Total-Body Irra...
18 Years - 65 YearsCity of Hope Medical Center
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityNCT03032783
Hematopoietic a...
Total-Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Tacrolimus
Mycophenolate M...
Allogeneic Hema...
18 Years - Thomas Jefferson University
Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNCT00119392
B-cell Chronic ...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Splenic Margina...
Waldenström Mac...
rituximab
cyclosporine
fludarabine pho...
mycophenolate m...
yttrium Y 90 ib...
peripheral bloo...
allogeneic hema...
total-body irra...
18 Years - Fred Hutchinson Cancer Center
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid LeukemiaNCT00003145
Accelerated Pha...
Childhood Chron...
Chronic Myeloge...
Chronic Phase o...
Recurrent Disea...
Fludarabine Pho...
Total-Body Irra...
Nonmyeloablativ...
Peripheral Bloo...
Cyclosporine
Mycophenolate M...
Therapeutic All...
Laboratory Biom...
- 74 YearsFred Hutchinson Cancer Center
Allo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyNCT02487069
Acute Leukemia
Chronic Myeloid...
Myelodysplastic...
HSCT from MSD
HSCT from MUD
HSCT from HRD
Cyclosporin A
Methotrexate
Antithymocyte g...
Mycophenolate m...
18 Years - 60 YearsNanfang Hospital, Southern Medical University
Hematopoietic Stem Cell Transplantation in the Treatment of Infant LeukemiaNCT00357565
Leukemia
Myelodysplastic...
Childhood Acute...
Recurrent Child...
Secondary Acute...
Childhood Acute...
Previously Trea...
Secondary Myelo...
Refractory Anem...
Refractory Anem...
Refractory Anem...
De Novo Myelody...
Childhood Myelo...
filgrastim
busulfan
cyclosporine
fludarabine pho...
melphalan
mycophenolate m...
umbilical cord ...
- 3 YearsMasonic Cancer Center, University of Minnesota
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesNCT00824135
Hematologic Mal...
Clofarabine
Stem Cell Trans...
OKT3
Thiotepa
Melphalan
Mycophenolate m...
Rituximab
G-CSF
- 21 YearsSt. Jude Children's Research Hospital
Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyNCT00303719
Kidney Cancer
Leukemia
Lymphoma
Multiple Myelom...
Plasma Cell Neo...
Myelodysplastic...
anti-thymocyte ...
cyclophosphamid...
cyclosporine
fludarabine
mycophenolate m...
stem cell trans...
total body irra...
filgrastim
- 75 YearsMasonic Cancer Center, University of Minnesota
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesNCT00376519
Graft Versus Ho...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
Secondary Myelo...
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
Treg cell infus...
umbilical cord ...
total-body irra...
18 Years - 45 YearsMasonic Cancer Center, University of Minnesota
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesNCT01341301
Hematologic Mal...
Total Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Allogeneic hema...
Laboratory biom...
18 Years - Thomas Jefferson University
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and RituximabNCT00946023
Lymphoma
B-cell Lymphoma
Non Hodgkin Lym...
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Total body irra...
Tacrolimus
Mycophenolate M...
Rituximab
Allogeneic Bone...
1 Year - 75 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesNCT06013423
Acute Leukemia ...
Acute Lymphobla...
Acute Myeloid L...
Blastic Plasmac...
Hematopoietic a...
Mixed Phenotype...
Myelodysplastic...
Myeloproliferat...
Non-Hodgkin Lym...
Chronic Myeloid...
Biospecimen Col...
Bone Marrow Asp...
Cyclophosphamid...
Cyclosporine
Diagnostic Imag...
Echocardiograph...
Fludarabine Pho...
Multigated Acqu...
Mycophenolate M...
Survey Administ...
Thiotepa
Total-Body Irra...
Umbilical Cord ...
6 Months - 65 YearsFred Hutchinson Cancer Center
Haplo Peripheral Blood Sct In GVHD PreventionNCT04473911
GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphom...
Non Hodgkin Lym...
Blood Stem Cell...
Graft Vs Host D...
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
Myeloproliferat...
Chronic Myelomo...
Chemosensitive ...
FLUDARABINE
CYCLOPHOSPHAMID...
TBI
Melphalan
Sirolimus
Mycophenolate m...
RGI-2001
CYCLOPHOSPHAMID...
18 Years - 80 YearsMassachusetts General Hospital
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and RituximabNCT00946023
Lymphoma
B-cell Lymphoma
Non Hodgkin Lym...
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Total body irra...
Tacrolimus
Mycophenolate M...
Rituximab
Allogeneic Bone...
1 Year - 75 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic LeukemiaNCT01824693
Juvenile Myelom...
Allogeneic Hema...
Busulfan
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Pharmacological...
Tacrolimus
3 Months - 18 YearsChildren's Oncology Group
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic MalignancyNCT01807611
Leukemia
Lymphoma
Total Lymphoid ...
Fludarabine
Cyclophosphamid...
Thiotepa
Melphalan
HPC,A Infusion
TC-NK Infusion
G-CSF
Mesna
CliniMACS
Mycophenolate m...
- 21 YearsSt. Jude Children's Research Hospital
90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaNCT01503242
Plasma Cell Mye...
Refractory Plas...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Mycophenolate M...
Peripheral Bloo...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - 65 YearsFred Hutchinson Cancer Center
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)NCT02441803
Leukemia
Busulfan
Fludarabine
Clofarabine
Total Body Irra...
Thymoglobulin
Stem Cell Infus...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Decitabine
Cytarabine
Idarubicin
18 Years - 60 YearsM.D. Anderson Cancer Center
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesNCT00824135
Hematologic Mal...
Clofarabine
Stem Cell Trans...
OKT3
Thiotepa
Melphalan
Mycophenolate m...
Rituximab
G-CSF
- 21 YearsSt. Jude Children's Research Hospital
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSNCT01300572
Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center
Fucosylated T Cells for Graft Versus Host Disease (GVHD) PreventionNCT02423915
Leukemia
Lymphoma
Rituximab
Fludarabine
Cyclophosphamid...
Total Body Radi...
Fucosylated Reg...
Cord Blood Infu...
Mycophenolate m...
Sirolimus
Bone Marrow Asp...
G-CSF
Non-Fucosylated...
18 Years - 80 YearsM.D. Anderson Cancer Center
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic MalignanciesNCT02120157
Myeloablative C...
HLA-mismatched ...
Graft Survival
Transplantation...
Cyclophosphamid...
TBI
Busulfan
Unmanipulated B...
Tacrolimus
Mycophenolate m...
6 Months - 25 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell TransplantNCT05031897
Acute Lymphobla...
Acute Myeloid L...
Aplastic Anemia
Chronic Lymphoc...
Chronic Myelomo...
Essential Throm...
Hematopoietic a...
Hodgkin Lymphom...
Myelodysplastic...
Myelofibrosis
Myeloid Leukemi...
Myeloid Neoplas...
Non-Hodgkin Lym...
Plasma Cell Mye...
Polycythemia Ve...
Small Lymphocyt...
Hematopoietic C...
Mycophenolate M...
Tacrolimus
Cyclophosphamid...
Total-Body Irra...
Donor Lymphocyt...
Fludarabine
Melphalan
18 Years - Thomas Jefferson University
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerNCT00027820
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Childhood Renal...
Chronic Myelomo...
Clear Cell Rena...
de Novo Myelody...
Metastatic Rena...
Previously Trea...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Anem...
Refractory Anem...
Refractory Chil...
Refractory Chro...
Renal Medullary...
Type 1 Papillar...
Type 2 Papillar...
Untreated Adult...
Untreated Adult...
Untreated Child...
Fludarabine Pho...
Total-Body Irra...
Peripheral Bloo...
Nonmyeloablativ...
Cyclosporine
Mycophenolate M...
- Fred Hutchinson Cancer Center
2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological MalignanciesNCT03712878
Hematopoietic a...
Total-Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Allogeneic Hema...
Tacrolimus
Mycophenolate M...
18 Years - Thomas Jefferson University
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaNCT00006233
Melanoma (Skin)
therapeutic all...
cyclosporine
fludarabine pho...
mycophenolate m...
peripheral bloo...
radiation thera...
18 Years - 64 YearsFred Hutchinson Cancer Center
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisNCT02593123
Hodgkin's Lymph...
Lymphoid Leukem...
Lymphoma
Leukemia
Myeloma
Acute Lymphocyt...
Non Hodgkin Lym...
Chronic Lymphoc...
Multiple Myelom...
Chronic Myeloge...
Myelodysplastic...
Recurrent Acute...
Recurrent Hodgk...
Recurrent Non-H...
Recurrent Plasm...
Recurrent Chron...
Recurrent Chron...
Acute Myelogeno...
mycophenolate m...
Sargramostim
Filgrastim
18 Years - 74 YearsVirginia Commonwealth University
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant DiseasesNCT04083183
Non-Malignant N...
Astatine At 211...
Fludarabine
Cyclophosphamid...
Lapine T-Lympho...
Total-Body Irra...
Hematopoietic C...
Mycophenolate M...
Sirolimus
Bone Marrow Asp...
Biospecimen Col...
18 Years - 49 YearsFred Hutchinson Cancer Center
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis RegimensNCT01428973
Graft-Versus-Ho...
Hematological M...
Mycophenolate m...
Sirolimus
16 Years - 75 YearsUniversity of Liege
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesNCT02566304
Acute Myeloid L...
Acute Myeloid L...
Aplastic Anemia
Chronic Myelomo...
Hodgkin Lymphom...
Indolent Non-Ho...
Malignant Neopl...
Myelodysplastic...
Myeloproliferat...
Plasma Cell Mye...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Refractory Cyto...
Fludarabine
Total-Body Irra...
T Cell-Depleted...
Cyclophosphamid...
Peripheral Bloo...
Allogeneic Hema...
Tacrolimus
Mycophenolate m...
Laboratory Biom...
18 Years - Thomas Jefferson University
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)NCT02702960
Fibrolamellar H...
Hepatocellular ...
Hepatocellular ...
living related ...
Total body irra...
Bone marrow tra...
Cyclophosphamid...
Mesna
Filgrastim
Tacrolimus
mycophenolate m...
Prednisone
Antithymocyte g...
fludarabine
16 Years - 65 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantNCT01251575
Adult Acute Lym...
Adult Acute Mye...
Adult Diffuse L...
Adult Myelodysp...
Adult Non-Hodgk...
Aggressive Non-...
Childhood Acute...
Childhood Acute...
Childhood Diffu...
Childhood Myelo...
Childhood Non-H...
Chronic Lymphoc...
Chronic Lymphoc...
Chronic Phase C...
Hematopoietic a...
Mantle Cell Lym...
Plasma Cell Mye...
Prolymphocytic ...
Recurrent Chron...
Refractory Chro...
T-Cell Prolymph...
Waldenstrom Mac...
Recurrent Diffu...
Recurrent Hodgk...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNCT01707004
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
decitabine
fludarabine pho...
busulfan
cyclophosphamid...
tacrolimus
mycophenolate m...
filgrastim
total-body irra...
allogeneic bone...
laboratory biom...
18 Years - 75 YearsUniversity of Wisconsin, Madison
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantNCT02333162
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Hemat...
Fludarabine Pho...
Melphalan
Intensity-Modul...
Total Marrow Ir...
Allogeneic Hema...
Peripheral Bloo...
Allogeneic Bone...
Tacrolimus
Mycophenolate M...
Laboratory Biom...
18 Years - 75 YearsUniversity of Chicago
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersNCT00003572
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
peripheral bloo...
mycophenolate m...
tacrolimus
allogeneic bone...
radiation thera...
18 Years - 70 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell TransplantNCT01252667
Acute Myeloid L...
Allogeneic Hema...
Clofarabine
Cyclosporine
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
2 Years - Fred Hutchinson Cancer Center
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed LymphomaNCT02652468
Lymphoma
Fludarabine Pho...
Mesna
Cyclophosphamid...
Total nodal irr...
T Cell-Depleted...
Allogeneic Hema...
Peripheral Bloo...
Mycophenolate M...
Tacrolimus
Rituximab
18 Years - 75 YearsUniversity of Wisconsin, Madison
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation CyclophosphamideNCT01342289
Hodgkin's Lymph...
Leukemia
Myelodysplastic...
Multiple Myelom...
Non Hodgkin's L...
Cyclophosphamid...
Fludarabine
Total body irra...
Mycophenolate M...
Tacrolimus 60
Tacrolimus 90
Tacrolimus 120
Bone marrow tra...
6 Months - 75 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesNCT05170828
Acute Leukemia
Myelodysplastic...
T-lymphoblastic...
Acute Lymphocyt...
Acute Myeloid L...
Acute Biphenoty...
Acute Undiffere...
Cyclophosphamid...
Fludarabine
Total Body Irra...
Busulfan
Mesna
Sirolimus
Mycophenolate M...
Filgrastim
Cyclophosphamid...
Bone Marrow Tra...
18 Years - 70 YearsOssium Health, Inc.
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesNCT04959175
Hematologic Neo...
Mycophenolate M...
Allogeneic HSCT
Fludarabine
Sirolimus
Filgrastim
Cyclophosphamid...
Mesna
Total Body Irra...
12 Years - 85 YearsNational Institutes of Health Clinical Center (CC)
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeNCT03670966
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Chronic Myelomo...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Refractory Acut...
Refractory Acut...
Recurrent Mixed...
Refractory Mixe...
Hematopoietic a...
Astatine At 211...
Cyclophosphamid...
Total-Body Irra...
Peripheral Bloo...
Bone Marrow Tra...
Mycophenolate M...
Recombinant Gra...
Fludarabine Pho...
Tacrolimus
Bone Marrow Asp...
Biospecimen Col...
18 Years - 75 YearsFred Hutchinson Cancer Center
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary MyelofibrosisNCT04370301
Primary Myelofi...
Secondary Myelo...
Cyclophosphamid...
JAK Inhibitor
Fludarabine
Recombinant Gra...
Melphalan
Mycophenolate M...
Peripheral Bloo...
Tacrolimus
Total-Body Irra...
Computed Tomogr...
Magnetic Resona...
Bone Marrow Bio...
Bone Marrow Asp...
Biospecimen Col...
Echocardiograph...
Multigated Acqu...
18 Years - Fred Hutchinson Cancer Center
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeNCT00119366
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Myelo...
Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Secondary Acute...
Secondary Myelo...
iodine I 131 mo...
fludarabine pho...
total-body irra...
allogeneic hema...
peripheral bloo...
cyclosporine
mycophenolate m...
laboratory biom...
16 Years - 50 YearsFred Hutchinson Cancer Center
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of GlioblastomaNCT05236036
Astrocytoma
Glioblastoma
Glioblastoma, I...
MGMT-Unmethylat...
Recurrent Gliob...
Mycophenolate M...
Quality-of-Life...
Radiation Thera...
Temozolomide
18 Years - Northwestern University
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related DonorsNCT01349101
Hematological M...
Total Body Irra...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Fludarabine
Busulfan
Hematopoietic s...
18 Years - Thomas Jefferson University
Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionNCT00045435
Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
nonmyeloablativ...
fludarabine pho...
total-body irra...
cyclosporine
mycophenolate m...
peripheral bloo...
55 Years - Fred Hutchinson Cancer Center
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaNCT00093743
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
Fanconi Anemia
Previously Trea...
fludarabine pho...
cyclosporine
total-body irra...
allogeneic bone...
allogeneic hema...
peripheral bloo...
mycophenolate m...
- Fred Hutchinson Cancer Center
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerNCT00290641
Chronic Myelopr...
Leukemia
Lymphoma
Myelodysplastic...
filgrastim
graft-versus-tu...
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
umbilical cord ...
radiation thera...
- 45 YearsMasonic Cancer Center, University of Minnesota
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantNCT01251575
Adult Acute Lym...
Adult Acute Mye...
Adult Diffuse L...
Adult Myelodysp...
Adult Non-Hodgk...
Aggressive Non-...
Childhood Acute...
Childhood Acute...
Childhood Diffu...
Childhood Myelo...
Childhood Non-H...
Chronic Lymphoc...
Chronic Lymphoc...
Chronic Phase C...
Hematopoietic a...
Mantle Cell Lym...
Plasma Cell Mye...
Prolymphocytic ...
Recurrent Chron...
Refractory Chro...
T-Cell Prolymph...
Waldenstrom Mac...
Recurrent Diffu...
Recurrent Hodgk...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaNCT01008462
B-Cell Prolymph...
Hypodiploidy
Loss of Chromos...
Plasma Cell Leu...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Chron...
Recurrent Plasm...
Recurrent Small...
Refractory Chil...
Refractory Chro...
Refractory Non-...
Refractory Plas...
Refractory Smal...
t(14;16)
t(4;14)
T-Cell Prolymph...
Waldenstrom Mac...
Allogeneic Bone...
Allogeneic Hema...
Autologous Hema...
Autologous-Allo...
Carmustine
Cyclophosphamid...
Cytarabine
Etoposide
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Peripheral Bloo...
Tacrolimus
Total-Body Irra...
- 75 YearsFred Hutchinson Cancer Center
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerNCT00782379
Leukemia
Lymphoma
Myelodysplastic...
busulfan
cyclophosphamid...
fludarabine pho...
mycophenolate m...
tacrolimus
allogeneic hema...
peripheral bloo...
18 Years - 60 YearsNorthside Hospital, Inc.
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaNCT00093743
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
Fanconi Anemia
Previously Trea...
fludarabine pho...
cyclosporine
total-body irra...
allogeneic bone...
allogeneic hema...
peripheral bloo...
mycophenolate m...
- Fred Hutchinson Cancer Center
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaNCT04262843
Acute Lymphobla...
Acute Myeloid L...
High Risk Myelo...
Myelodysplastic...
Cyclophosphamid...
Fludarabine
Fludarabine Pho...
Granulocyte Col...
Hematopoietic C...
Intensity-Modul...
Mycophenolate M...
Tacrolimus
12 Years - 60 YearsCity of Hope Medical Center
NK Cells in Cord Blood TransplantationNCT01619761
Accelerated Pha...
Acute Biphenoty...
Acute Lymphobla...
Acute Myeloid L...
Chronic Phase C...
DS Stage II Pla...
DS Stage III Pl...
High Grade B-Ce...
ISS Stage II Pl...
ISS Stage III P...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Recurrent Chron...
Recurrent Hodgk...
Recurrent Non-H...
Recurrent Small...
Refractory Acut...
Refractory Chro...
Refractory Hodg...
Refractory Non-...
Refractory Smal...
Secondary Acute...
Therapy-Related...
Therapy-Related...
Allogeneic Hema...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Lenalidomide
Melphalan
Mycophenolate M...
Natural Killer ...
Rituximab
Tacrolimus
Total-Body Irra...
Umbilical Cord ...
- 75 YearsM.D. Anderson Cancer Center
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesNCT00566696
Leukemia, Acute...
Leukemia, Myelo...
Leukemia, Myelo...
Juvenile Myelom...
Hemoglobinuria,...
Hodgkin Lymphom...
Lymphoma, Non-H...
Myelodysplastic...
CliniMACS
Stem cell trans...
Fludarabine
Thioplex®
L-phenylalanine...
Mycophenolate m...
Rituxan™
Alemtuzumab
Cyclophosphamid...
Anti-thymocyte ...
G-CSF
Muromonab
- 21 YearsSt. Jude Children's Research Hospital
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisNCT06001385
Acute Lymphobla...
Acute Myeloid L...
Acute Leukemia
Myelodysplastic...
Chronic Myeloid...
Chronic Lymphoc...
Myeloproliferat...
Lymphoma
Chronic Myelomo...
Pro-Lymphocytic...
Myelofibrosis
Busulfan
Fludarabine
PBSC Hematopoie...
Post-Transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient Reporte...
Melphalan
Total-body irra...
Cyclophosphamid...
18 Years - Center for International Blood and Marrow Transplant Research
Haplo Peripheral Blood Sct In GVHD PreventionNCT04473911
GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphom...
Non Hodgkin Lym...
Blood Stem Cell...
Graft Vs Host D...
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
Myeloproliferat...
Chronic Myelomo...
Chemosensitive ...
FLUDARABINE
CYCLOPHOSPHAMID...
TBI
Melphalan
Sirolimus
Mycophenolate m...
RGI-2001
CYCLOPHOSPHAMID...
18 Years - 80 YearsMassachusetts General Hospital
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesNCT01471067
Blood And Marro...
Leukemia
Lymphoma
Transplantation...
Transplantation...
Melphalan
Fludarabine
Mycophenolate m...
Tacrolimus
Cord Blood Infu...
Rituximab
ATG
Busulfan
Clofarabine
Total Body Irra...
1 Year - 80 YearsM.D. Anderson Cancer Center
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantNCT01231412
Acute Lymphobla...
Acute Myeloid L...
Aggressive Non-...
Chronic Lymphoc...
Diffuse Large B...
Hematopoietic a...
Indolent Non-Ho...
Mantle Cell Lym...
Myelodysplastic...
Myeloproliferat...
Prolymphocytic ...
Recurrent Chron...
Recurrent Plasm...
Refractory Chro...
Refractory Chro...
Refractory Hodg...
Small Lymphocyt...
T-Cell Chronic ...
Waldenstrom Mac...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaNCT04205240
Recurrent Plasm...
Allogeneic Hema...
Cyclophosphamid...
Daratumumab
Fludarabine
Melphalan
Mycophenolate M...
Tacrolimus
18 Years - 75 YearsOhio State University Comprehensive Cancer Center
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney CancerNCT00005851
Recurrent Renal...
Stage IV Renal ...
fludarabine pho...
total-body irra...
nonmyeloablativ...
cyclosporine
mycophenolate m...
peripheral bloo...
therapeutic all...
laboratory biom...
- 74 YearsFred Hutchinson Cancer Center
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSNCT01300572
Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisNCT03426969
Primary Myelofi...
Secondary Myelo...
Cyclophosphamid...
Filgrastim
Fludarabine Pho...
Hematopoietic C...
Melphalan
Mycophenolate M...
Tacrolimus
Total-Body Irra...
18 Years - 70 YearsM.D. Anderson Cancer Center
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaNCT00006233
Melanoma (Skin)
therapeutic all...
cyclosporine
fludarabine pho...
mycophenolate m...
peripheral bloo...
radiation thera...
18 Years - 64 YearsFred Hutchinson Cancer Center
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative DisordersNCT00397813
Atypical Chroni...
Chronic Myelomo...
de Novo Myelody...
Essential Throm...
Myeloproliferat...
Paroxysmal Noct...
Polycythemia Ve...
Polycythemia Ve...
Primary Myelofi...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Refractory Cyto...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Nonmyeloablativ...
Peripheral Bloo...
Total-Body Irra...
50 Years - 75 YearsFred Hutchinson Cancer Center
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantNCT04022239
Hematopoietic a...
Allogeneic Hema...
Bendamustine
Cyclophosphamid...
Filgrastim-sndz
Fludarabine
Melphalan
Mycophenolate M...
Rituximab
Tacrolimus
Total-Body Irra...
18 Years - 70 YearsM.D. Anderson Cancer Center
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaNCT04205240
Recurrent Plasm...
Allogeneic Hema...
Cyclophosphamid...
Daratumumab
Fludarabine
Melphalan
Mycophenolate M...
Tacrolimus
18 Years - 75 YearsOhio State University Comprehensive Cancer Center
Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyNCT00303719
Kidney Cancer
Leukemia
Lymphoma
Multiple Myelom...
Plasma Cell Neo...
Myelodysplastic...
anti-thymocyte ...
cyclophosphamid...
cyclosporine
fludarabine
mycophenolate m...
stem cell trans...
total body irra...
filgrastim
- 75 YearsMasonic Cancer Center, University of Minnesota
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)NCT05049863
Small-cell Lung...
Small Cell Lung...
Mycophenolate M...
Allopurinol
Irinotecan
18 Years - Washington University School of Medicine
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaNCT00387959
Leukemia
Lymphoma
filgrastim
rituximab
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
allogeneic hema...
umbilical cord ...
total-body irra...
18 Years - 70 YearsMemorial Sloan Kettering Cancer Center
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCTNCT02627573
Leukemia, Chron...
Myelodysplastic...
Leukemia, Myelo...
Unrelated allog...
Busulfan
Fludarabine mon...
Tacrolimus
Mycophenolate m...
Cyclophosphamid...
Thymoglobulin
18 Years - 75 YearsSt. Petersburg State Pavlov Medical University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: